RankAlpha logo
Back to Rankings

PALI

Palisade BioB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
PALI vs peer average
73/100
PALI vs. peer average (B vs. C)
Grade spread
A 2 · C 2 · D 5 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

RLMD is the first available peer comparator.

Clinical-stage small-cap biotech with binary program catalysts and financing sensitivity; useful comparator for how pre-proof-of-concept drug developers rerate around trial updates.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerRLMDRelmada Therapeutics
PALI
Palisade Bio
RLMD
Relmada Therapeutics
Grade
B
C
Momentum
85
24
Value
41
41
Sentiment
47
83
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Mixed
Open Side-by-Side ComparisonCompare all

Grade position vs RLMD

PALI / RLMD
Grade Position
Above peers
PALI vs. peer average (B vs. C)
73/100
Momentum
85
PALI
Value
41
PALI
Sentiment
47
RLMD

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs PALI
1
RLMD
RLMD
C
60/100
+1
2
ALLO
ALLO
A
100/100
-1
3
TLSI
TLSI
F
20/100
+3
4
CATX
Perspective Therapeutics Inc Common
C
60/100
+1
5
ORGO
Organogenesis Holdings Inc Class A Common
D
40/100
+2
RLMD is the first peer returned for this comparison set.